ClassID:

21647

A61K2300/00 - page 10 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#2701
20180098992
2018-04-12

ANTIVIRAL THERAPY

#2702
20180098991
2018-04-12

COMPOSITION FOR LIPID DISORDER TREATMENT

#2703
20180098984
2018-04-12

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#2704
20180098972
2018-04-12

TREATMENT OF INFECTIOUS DISEASES

#2705
20180098971
2018-04-12

Transplantation Adjuvant in Cell Therapy Using Neural Progenitor Cells

#2706
20180098970
2018-04-12

USE OF ISOINDOLES FOR THE TREATMENT OF NEUROBEHAVIORAL DISORDERS

#2707
20180098967
2018-04-12

Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy

#2708
20180098966
2018-04-12

Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

#2709
20180098962
2018-04-12

Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same

#2710
20180098957
2018-04-12

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#2711
20180098949
2018-04-12

THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS

#2712
20180098940
2018-04-12

PEDIATRIC FORMULATION

#2713
20180098926
2018-04-12

TWO CONTAINER SKIN CARE PRODUCT

#2714
20180094262
2018-04-05

Inhibitors of MYH7B and uses thereof

#2715
20180094070
2018-04-05

Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor

#2716
20180094069
2018-04-05

Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor

#2717
20180094038
2018-04-05

Acylated glucagon analogue

#2718
20180094034
2018-04-05

INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS

#2719
20180094018
2018-04-05

Progesterone phosphate analogs and uses related thereto

#2720
20180093976
2018-04-05

Pyridazinone compounds and methods for the treatment of cystic fibrosis

#2721
20180093971
2018-04-05

Compounds for treatment of cancer

#2722
20180093947
2018-04-05

Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

#2723
20180092965
2018-04-05

Treatment type 2 diabetes mellitus patients

#2724
20180092933
2018-04-05

SMALL MOLECULE ENHANCER FOR DENDRITIC CELL CANCER VACCINES

#2725
20180092932
2018-04-05

Anti-viral azide containing compounds

#2726
20180092929
2018-04-05

Methods for suppressing allergic reactions

#2727
20180092922
2018-04-05

Methods used to treat cancer

#2728
20180092921
2018-04-05

Specific trifluoroethyl quinoline analogue for use in the treatment of Sjögren's syndrome

#2729
20180092906
2018-04-05

Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

#2730
20180092901
2018-04-05

Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer

#2731
20180092881
2018-04-05

Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder

#2732
20180092876
2018-04-05

Treating or preventing nephrogenic diabetes insipidus

#2733
20180092873
2018-04-05

Method of treating renal system damage

#2734
20180092872
2018-04-05

GEL COMPOSITION FOR TREATMENT OF COMMON ACNE COMPRISING A COMBINATION OF BENZOYL PEROZIDE AND ADAPALENE AND/OR ADAPALENE SALT

#2735
20180092869
2018-04-05

Pharmaceutical quality strontium L-lactate

#2736
20180092867
2018-04-05

Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4',9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol

#2737
20180092865
2018-04-05

Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder

#2738
20180092863
2018-04-05

ANTICOAGULANT COMPOUNDS AND THEIR USE

#2739
20180092862
2018-04-05

Antimicrobials and methods of use thereof for wound healing

#2740
20180092850
2018-04-05

Hydrogel encapsulated cells and anti-inflammatory drugs

#2741
20180092838
2018-04-05

DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS

#2742
20180092835
2018-04-05

Compositions for topical treatment of microbial infections

#2743
20180092821
2018-04-05

PERIODONTAL DISEASE TREATMENT

#2744
20180088131
2018-03-29

Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients

#2745
20180086830
2018-03-29

Antibody molecules to LAG-3 and uses thereof

#2746
20180086761
2018-03-29

Heterocyclic compounds and their use in preventing or treating bacterial infections

#2747
20180086750
2018-03-29

Histone deacetylase inhibitors and their use in therapy

#2748
20180086747
2018-03-29

Phosphatidylinositol 3-kinase inhibitors

#2749
20180086744
2018-03-29

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

#2750
20180086736
2018-03-29

RORC2 INHIBITORS AND METHODS OF USE THEREOF

#2751
20180086719
2018-03-29

Phosphatidylinositol 3-kinase inhibitors

#2752
20180086680
2018-03-29

Ethynyl derivatives

#2753
20180085478
2018-03-29

Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents

#2754
20180085462
2018-03-29

Topical use of levofloxacin for reducing lung inflammation

#2755
20180085461
2018-03-29

Therapeutic treatments using centhaquin

#2756
20180085439
2018-03-29

Stabilised Solid Compositions of Factor VII Polypeptides

#2757
20180085432
2018-03-29

STING (Stimulator of Interferon Genes), A Regulator of Innate Immune Responses

#2758
20180085424
2018-03-29

BRAIN AND NEURAL TREATMENTS COMPRISING PEPTIDES AND OTHER COMPOSITIONS

#2759
20180085418
2018-03-29

Additives for animal feed

#2760
20180085398
2018-03-29

COMPOSITIONS AND METHODS OF TREATING CANCER

#2761
20180085393
2018-03-29

Compositions for sensitive skin

#2762
20180085392
2018-03-29

CYCLODEXTRIN COMPOUNDS FOR THE PREVENTION AND TREATMENT OF AGING

#2763
20180085380
2018-03-29

Composition for curing migraine headaches

#2764
20180085379
2018-03-29

Methods of monitoring estriol therapy

#2765
20180085376
2018-03-29

Use of aerosolized levofloxacin for treating cystic fibrosis

#2766
20180085374
2018-03-29

Use of Morpholino Compounds for the Treatment of Halitosis

#2767
20180085372
2018-03-29

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2768
20180085371
2018-03-29

COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM

#2769
20180085369
2018-03-29

Salts of quinazoline derivative and method for preparing the same

#2770
20180085367
2018-03-29

COMBINATIONS COMPRISING 3-PHENYLSULFONYL-8-PIPERAZINYL-1YL-QUINOLINE

#2771
20180085364
2018-03-29

PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF

#2772
20180085361
2018-03-29

NOVEL PHARMACEUTICAL USES

#2773
20180085359
2018-03-29

USE OF CHELATORS OF DIVALENT CATIONS TO PROMOTE NERVE REGENERATION

#2774
20180085357
2018-03-29

Crystalline compound as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitor

#2775
20180085353
2018-03-29

Controlled release pharmaceutical formulations of nitozoxanide

#2776
20180085350
2018-03-29

Compositions and methods of treating cancer

#2777
20180085341
2018-03-29

METHODS FOR TREATING CANCER

#2778
20180085334
2018-03-29

METHODS OF TREATING PEDIATRIC METABOLIC SYNDROME

#2779
20180085317
2018-03-29

Extended relief dosage form

#2780
20180084786
2018-03-29

Altering microbial populations and modifying microbiota

#2781
20180084785
2018-03-29

Altering microbial populations and modifying microbiota

#2782
20180079818
2018-03-22

METHOD OF INHIBITION OF LEUKEMIC STEM CELLS

#2783
20180079762
2018-03-22

Carbidopa and L-dopa prodrugs and methods of use

#2784
20180079737
2018-03-22

Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using same

#2785
20180079730
2018-03-22

ANTI-PCSK9 COMPOUNDS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES

#2786
20180078644
2018-03-22

COMBINATION OF CAROTENOIDS AND EPI-LUTEIN

#2787
20180078642
2018-03-22

Edible compositions

#2788
20180078623
2018-03-22

Methods and compositions for the treatment of symptoms of prion diseases

#2789
20180078618
2018-03-22

SYNERGISTIC GLYCOCALYX TREATMENT COMPOSITIONS AND METHODS

#2790
20180078601
2018-03-22

ORAL FORMULATIONS FOR PROMOTING CELLULAR PURIFICATION

#2791
20180078597
2018-03-22

Antiseptics

#2792
20180078578
2018-03-22

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND IMMUNOLOGICAL DISORDERS

#2793
20180078556
2018-03-22

Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin

#2794
20180078551
2018-03-22

Combination therapy with an antitumor alkaloid

#2795
20180078550
2018-03-22

COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID

#2796
20180078543
2018-03-22

Compositions of buprenorphine and μ antagonists

#2797
20180078542
2018-03-22

Compositions of buprenorphine and μ antagonists

#2798
20180078535
2018-03-22

THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF

#2799
20180078533
2018-03-22

Compounds and methods for treating influenza

#2800
20180078531
2018-03-22

Ocular formulations for drug-delivery and protection of the anterior segment of the eye

#2801
20180078526
2018-03-22

Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

#2802
20180078496
2018-03-22

ARTICLE OF MANUFACTURE COMPRISING AFLIBERCEPT OR ZIV-AFLIBERCEPT

#2803
20180078493
2018-03-22

TRANSDERMAL HORMONE DELIVERY

#2804
20180073078
2018-03-15

RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS

#2805
20180072687
2018-03-15

Heteroaryl compounds and uses thereof

#2806
20180072671
2018-03-15

Inhibitors of histone deacetylase

#2807
20180071432
2018-03-15

Compositions and methods for cardiac therapy

#2808
20180071375
2018-03-15

Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome

#2809
20180071359
2018-03-15

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#2810
20180071343
2018-03-15

ANGIOGENESIS USING PLACENTAL STEM CELLS

#2811
20180071339
2018-03-15

COMBINATION OF PHARMACEUTICAL PREPARATIONS FOR TUMOR CHEMOTHERAPY

#2812
20180071335
2018-03-15

METHOD AND APPARATUS FOR ESTABLISHING A KEY AGREEMENT PROTOCOL

#2813
20180071328
2018-03-15

Methods for the Effective Treatment of Metastatic Cancer

#2814
20180071325
2018-03-15

Cyclic boronic acid ester derivatives and methods of making the same

#2815
20180071320
2018-03-15

Methods and materials for treating calcific aortic valve stenosis

#2816
20180071318
2018-03-15

Vitamin D receptor/SMAD genomic circuit gates fibrotic response

#2817
20180071317
2018-03-15

USE OF AGENTS THAT ALTER THE PERITUMORAL ENVIRONMENT FOR THE TREATMENT OF CANCER

#2818
20180071314
2018-03-15

Dehydroandrosterol and methods of using the same

#2819
20180071310
2018-03-15

COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS

#2820
20180071303
2018-03-15

SYK INHIBITORS

#2821
20180071301
2018-03-15

Use of non-peptide NK1 antagonists in a predetermined dose for the treatment of cancer

#2822
20180071296
2018-03-15

COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM

#2823
20180071295
2018-03-15

BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF

#2824
20180071293
2018-03-15

TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY

#2825
20180071290
2018-03-15

Solid pharmaceutical formulation of PARP inhibitors and use thereof

#2826
20180071277
2018-03-15

ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER

#2827
20180071276
2018-03-15

Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists

#2828
20180071273
2018-03-15

NUTRITIONAL COMPOSITIONS TO ENHANCE MITOCHONDRIAL ENERGY PRODUCTION

#2829
20180071269
2018-03-15

THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS

#2830
20180071254
2018-03-15

Methods of treating dementia and pharmaceutical compositions thereof

#2831
20180071251
2018-03-15

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#2832
20180071247
2018-03-15

Combination of a PD-1 antagonist and eribulin for treating cancer

#2833
20180071246
2018-03-15

Enkephalin-influencing composition and method

#2834
20180071238
2018-03-15

Compositions and Methods for Traumatized Tissues Using Zinc Chelators

#2835
20180071237
2018-03-15

TREATMENT METHOD FOR IMPROVING INTESTINAL ENVIORNMENT AND INTESTINAL TRACT BARRIER

#2836
20180071233
2018-03-15

COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISEASES

#2837
20180071221
2018-03-15

IMMEDIATE RELEASE SOLUBLE IBUPROFEN COMPOSITIONS

#2838
20180071218
2018-03-15

Process for manufacturing dry powder blends

#2839
20180070594
2018-03-15

Altering microbial populations and modifying microbiota

#2840
20180066067
2018-03-08

ANTIBODIES AND METHODS FOR WNT PATHWAY-RELATED DISEASES

#2841
20180066040
2018-03-08

Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein

#2842
20180065968
2018-03-08

NEW SUBSTITUTED TRIAZOLOPYRIMIDINES AS ANTI-MALARIAL AGENTS

#2843
20180065932
2018-03-08

ANTIVIRAL COMPOUNDS

#2844
20180065912
2018-03-08

Methods of treating Parkinson's disease

#2845
20180064810
2018-03-08

USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING

#2846
20180064808
2018-03-08

COMBINATION THERAPY OF BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5 AND CHEMOTHERAPEUTIC AGENTS

#2847
20180064779
2018-03-08

Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

#2848
20180064775
2018-03-08

ANTI-PATHOGENIC COMPOSITIONS

#2849
20180064774
2018-03-08

Compositions for use in the treatment of tumors resistant to chemotherapy

#2850
20180064764
2018-03-08

Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof

#2851
20180064755
2018-03-08

Compositions and methods for treating drug addiction

#2852
20180064754
2018-03-08

MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF

#2853
20180064753
2018-03-08

Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent

#2854
20180064726
2018-03-08

Deuterium-Substituted Oxazepin Compounds

#2855
20180064725
2018-03-08

IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases

#2856
20180064724
2018-03-08

Methods for treating intrapulmonary infections

#2857
20180064722
2018-03-08

ANTIBACTERIAL COMPOSITIONS

#2858
20180064717
2018-03-08

Deuterated analogs of etifoxine, their derivatives and uses thereof

#2859
20180064713
2018-03-08

Modulators of Androgen Synthesis

#2860
20180064706
2018-03-08

ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE

#2861
20180064705
2018-03-08

Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome

#2862
20180064704
2018-03-08

IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE

#2863
20180064699
2018-03-08

Method of treating pulmonary arterial hypertension

#2864
20180064684
2018-03-08

Nintedanib diethanesulfonate salt crystal and preparation method and use thereof

#2865
20180064681
2018-03-08

THERAPEUTIC COMBINATIONS OF CURCUMINOIDS AND FLAVONOIDS

#2866
20180064680
2018-03-08

Derivatives of korormicin useful as antibiotics

#2867
20180064676
2018-03-08

Methods of treating or preventing prostate cancer

#2868
20180064668
2018-03-08

Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma

#2869
20180064662
2018-03-08

NOVEL COMPOSITIONS AND USES OF METFORMIN AGENTS

#2870
20180064660
2018-03-08

AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES

#2871
20180064657
2018-03-08

Bisphenol ether derivatives and methods for using the same

#2872
20180064649
2018-03-08

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

#2873
20180064622
2018-03-08

Compositions and methods for inhibiting hair growth

#2874
20180064115
2018-03-08

Altering microbial populations and modifying microbiota

#2875
20180064114
2018-03-08

Altering microbial populations and modifying microbiota

#2876
20180057819
2018-03-01

MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS

#2877
20180057606
2018-03-01

METHODS OF TREATING MENINGIOMA

#2878
20180057574
2018-03-01

Anti-histone therapy in acute kidney injury

#2879
20180057488
2018-03-01

Compositions and methods for inhibiting kinases

#2880
20180057456
2018-03-01

Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

#2881
20180055954
2018-03-01

Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

#2882
20180055896
2018-03-01

COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN

#2883
20180055888
2018-03-01

COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS

#2884
20180055874
2018-03-01

Fast acting joint relief formulations

#2885
20180055871
2018-03-01

Nutritional composition or pharmaceutical and dietary supplement containing said nutritional or pharmaceutical composition

#2886
20180055864
2018-03-01

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

#2887
20180055852
2018-03-01

Heterocyclic compounds and uses thereof

#2888
20180055844
2018-03-01

METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE

#2889
20180055828
2018-03-01

Kinase modulation, and indications therefor

#2890
20180055824
2018-03-01

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections

#2891
20180055809
2018-03-01

Treatment for ischemic stroke

#2892
20180055794
2018-03-01

Materials and methods for controlling infections

#2893
20180055793
2018-03-01

Materials and methods for controlling infections

#2894
20180055786
2018-03-01

Immediate release oral guaifenesin solution

#2895
20180055069
2018-03-01

Preparations having a cooling effect

#2896
20180051036
2018-02-22

Compound inhibiting activities of BTK and/or JAK3 kinases

#2897
20180050997
2018-02-22

Compounds and compositions for inhibition of FASN

#2898
20180050994
2018-02-22

RUFINAMIDE AND DERIVATIVES AND THEIR USE IN MODULATING THE GATING PROCESS OF HUMAN VOLTAGE-GATED SODIUM CHANNELS

#2899
20180050116
2018-02-22

Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use

#2900
20180050090
2018-02-22

COMPOSITIONS AND METHODS FOR SENSITIZING CELLS TO TRAIL-INDUCED APOPTOSIS

#2901
20180050088
2018-02-22

Ophthalmic compositions and methods of use therefor

#2902
20180050079
2018-02-22

ANGIOTENSIN PEPTIDES IN TREATING MARFAN SYNDROME AND RELATED DISORDERS

#2903
20180050061
2018-02-22

Roneparstat combined therapy of multiple myeloma

#2904
20180050039
2018-02-22

Induction of tumor hypoxia for cancer therapy

#2905
20180050031
2018-02-22

Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl Fumarate

#2906
20180050029
2018-02-22

SELECTIVE CONNEXIN HEMICHANNELS BLOCKERS FOR THE TREATMENT OF EPILEPSY

#2907
20180050023
2018-02-22

Oxybutynin-xanomeline transdermal therapeutic system combinations

#2908
20180050014
2018-02-22

Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer

#2909
20180050012
2018-02-22

Method for Inhibiting Growth of Ovarian Cancer Cells

#2910
20180050008
2018-02-22

Oxybutynin transdermal therapeutic system muscarinic agonist combination

#2911
20180049999
2018-02-22

COMPOSITIONS AND METHODS OF TREATMENT OF BREAST DISORDERS AND ESTROGEN-RELATED DISORDERS

#2912
20180049979
2018-02-22

Liquisoft capsules

#2913
20180049973
2018-02-22

Cosmetic Compostions

#2914
20180049449
2018-02-22

Preparations

#2915
20180044355
2018-02-15

Tricyclic benzoxaborole compounds and uses thereof

#2916
20180044330
2018-02-15

Phthalazinone compounds and methods for the treatment of cystic fibrosis

#2917
20180044314
2018-02-15

Method of treating or preventing Ras-mediated diseases

#2918
20180044300
2018-02-15

Azepane derivatives and methods of treating hepatitis B infections

#2919
20180044292
2018-02-15

Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

#2920
20180043029
2018-02-15

Stabilized polymeric carriers for therapeutic agent delivery

#2921
20180043014
2018-02-15

Compositions Using Antibodies Directed to GPNMB and Uses Thereof

#2922
20180043000
2018-02-15

TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN

#2923
20180042989
2018-02-15

IMMUNOMODULATORY COMPOSITIONS

#2924
20180042975
2018-02-15

PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER

#2925
20180042974
2018-02-15

SANDALWOOD OIL AND ITS USES

#2926
20180042964
2018-02-15

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

#2927
20180042958
2018-02-15

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

#2928
20180042957
2018-02-15

Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof

#2929
20180042953
2018-02-15

ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION

#2930
20180042951
2018-02-15

Glucocerebroside treatment of liver disorders

#2931
20180042941
2018-02-15

CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS

#2932
20180042938
2018-02-15

NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT

#2933
20180042936
2018-02-15

MAINTENANCE THERAPY USING TIANEPTINE

#2934
20180042929
2018-02-15

USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES

#2935
20180042923
2018-02-15

COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER

#2936
20180042901
2018-02-15

Drug compositions comprising an anti-parasitic and proton pump inhibitor

#2937
20180042899
2018-02-15

Method of Treating Transplant Rejection and Autoimmune Diseases

#2938
20180042898
2018-02-15

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL

#2939
20180042896
2018-02-15

Use of amisulpride as an anti-emetic

#2940
20180042883
2018-02-15

Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject

#2941
20180042879
2018-02-15

Free amino acid preparation and uses thereof

#2942
20180042870
2018-02-15

USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES

#2943
20180042869
2018-02-15

THERAPEUTIC AGENTS FOR USE IN THE PROPYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS

#2944
20180042240
2018-02-15

Antimicrobial compositions

#2945
20180037957
2018-02-08

Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

#2946
20180037895
2018-02-08

COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES

#2947
20180037622
2018-02-08

Methods for treating refractory anemia with ringed sideroblasts

#2948
20180037589
2018-02-08

Thienodiazepine derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition including the same as an active ingredient

#2949
20180037557
2018-02-08

Prodrugs of riluzole and their method of use

#2950
20180037545
2018-02-08

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

#2951
20180036516
2018-02-08

Drug releasing coatings for balloon catheters

#2952
20180036439
2018-02-08

COUPLED IDENTIFICATION AND TREATMENT OF CANCER

#2953
20180036389
2018-02-08

Dodecafluoropentane emulsion as a stroke and ischemia therapy

#2954
20180036382
2018-02-08

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE

#2955
20180036380
2018-02-08

Treatments for migraine and related disorders

#2956
20180036377
2018-02-08

Methods for treating metabolic disorders using FGF

#2957
20180036366
2018-02-08

ADMINSTRATION OF RECOMBINANT COLLAGEN 7 FOR THE TREATMENT OF AGE RELATED DISORDERS

#2958
20180036361
2018-02-08

Compositions and methods for treatment of pain

#2959
20180036358
2018-02-08

COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS

#2960
20180036346
2018-02-08

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

#2961
20180036345
2018-02-08

EXPANSION OF ALLOANTIGEN-REACTIVE REGULATORY T CELLS

#2962
20180036342
2018-02-08

Increasing the half-life of hydrogen peroxide in an ingestible composition

#2963
20180036340
2018-02-08

Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

#2964
20180036325
2018-02-08

L-ARABINOSE PLUS CHROMIUM FOR CONTROLLING THE METABOLIZATION OF SUCROSE

#2965
20180036290
2018-02-08

Riluzole prodrugs and their use

#2966
20180036285
2018-02-08

Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage

#2967
20180036281
2018-02-08

Pharmaceutical for prophylaxis or treatment of hypertension

#2968
20180036280
2018-02-08

PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER

#2969
20180036276
2018-02-08

Combination comprising N-acetyl-L-cysteine and its use

#2970
20180036275
2018-02-08

Combination of a retinoid and a diol and polyunsaturated fatty acid ester

#2971
20180036274
2018-02-08

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

#2972
20180036273
2018-02-08

Method and medicines for treating melanoma

#2973
20180036257
2018-02-08

ZEAXANTHIN FOR TUMOR TREATMENT

#2974
20180036231
2018-02-08

PREVENTION OF AND RECOVERY FROM DRUG-INDUCED OTOTOXICITY

#2975
20180036220
2018-02-08

HYALURONIC ACID PARTICLES FOR COSMETIC OR DERMATOLOGICAL USES

#2976
20180030502
2018-02-01

Regulation of Autophagy and Cell Survival

#2977
20180029997
2018-02-01

Quinazolinone antibiotics

#2978
20180028665
2018-02-01

Liquid formulation

#2979
20180028660
2018-02-01

DRUG COMBINATIONS COMPRISING A DGAT INHIBITOR AND A PPAR-AGONIST

#2980
20180028621
2018-02-01

METHODS OF INDUCING INDOLAMINE 2,3 - DIOXYGENASE (IDO)

#2981
20180028607
2018-02-01

Methods of treatment for retinal diseases using MANF and CNDF

#2982
20180028598
2018-02-01

Compostions for Treating Dry Eye Disease

#2983
20180028583
2018-02-01

Cancer therapy with a parvovirus combined with bevacizumab

#2984
20180028561
2018-02-01

Method for preparing a liposomal rehydration salt formulation

#2985
20180028556
2018-02-01

Methods of treating optic disorders

#2986
20180028519
2018-02-01

Use of Flecainide as an Anti-Connexin Agent and Method for Potentiating the Effects of a Psychotropic Drug

#2987
20180028517
2018-02-01

Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis

#2988
20180028509
2018-02-01

Substituted quinolizine derivatives useful as HIV integrase inhibitors

#2989
20180028484
2018-02-01

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma

#2990
20180028469
2018-02-01

Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same

#2991
20180028422
2018-02-01

Composition with insect repellent activity

#2992
20180023146
2018-01-25

3.beta-hydroxysteroid dehydrogenase in steroid dependent disease

#2993
20180023085
2018-01-25

IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE

#2994
20180022738
2018-01-25

3-substituted cyclopentylamine derivatives

#2995
20180022737
2018-01-25

Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide

#2996
20180022730
2018-01-25

Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof

#2997
20180022714
2018-01-25

Substituted quinoxalines for inhibiting kinase activity

#2998
20180021553
2018-01-25

Drug releasing coatings for medical devices

#2999
20180021480
2018-01-25

Composition comprising hyaluronic acid and mepivacaine

#3000
20180021406
2018-01-25

Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin